Andere Sprachen Xiamen Amoytop Biotech Co., Ltd.

Aktien

688278

CNE100003RT3

688278

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 30.04.2024			% 5 Tage	% 1. Jan.
60,51 ^CNY	-0,31 %		-6,43 %	+15,59 %

22.04.	Xiamen Amoytop Biotech Co., Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
18.03.	Chinesische Aktien legen aufgrund positiver Wirtschaftsdaten zu; Amoytop Biotech steigt um 6%	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22.04.
China Stocks Advance Over Positive Economic Data; Amoytop Biotech Rises 6%	18.03.
Xiamen Amoytop Biotech Gets Nod to Market Hepatitis Drug; Shares Up 4%	18.03.
Amoytop Biotech's 2023 Profit Jumps 93%	26.02.
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23.02.
'Hawkish' China military squeeze on Taiwan likely after election	03.01.
Taiwan not seeing signs of large-scale Chinese military activity pre-election	26.12.
Taiwan to 'handle' spate of Chinese balloons based on threat level	20.12.
Taiwan reports more suspected Chinese weather balloons crossing Taiwan Strait	18.12.
Xiamen Amoytop Biotech Co., Ltd.(SHSE:688278) added to Shanghai Stock Exchange Health Care Sector Index	11.12.
Amoytop Biotech Signs Exclusive License Deal for Liver Disease Drug With Alphamab Unit	07.12.
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	19.10.23
Taiwan raises concerns about situation 'getting out of hand' with China drills	23.09.23
Xiamen Amoytop Biotech Co., Ltd.(XSSC:688278) added to S&P Global BMI Index	18.09.23
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17.08.23
Amoytop Biotech Signs Exclusive Commercialization Deal With Fosun Unit	01.06.23
Sector Update: Health Care Stocks Edge Higher Premarket Monday	15.05.23
Top Premarket Gainers	15.05.23
Aligos Therapeutics to Collaborate with Xiamen Amoytop Biotech on Liver Disease Treatments; Aligos Shares Jump	15.05.23
Huihe Biotechnology Co., Ltd. announced that it has received CNY 100 million in funding from Shanghai Prosperico Ventures Co., Ltd., Shenzhen Capital Group Co., Ltd., Jolmo Investment Management Co., Ltd., Xiamen Amoytop Biotech Co., Ltd., Hangzhou Tailong Venture Capital Partnership Enterprise (L.P.)	15.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Xiamen Amoytop Biotech Co., Ltd.

Aktien

688278

CNE100003RT3

688278

Andere Sprachen

Filter